Swiercz's study[47] indicated Plexin-B1 stimulated tumor cell migration via tyrosine kinase receptor ErbB-2 pathway while antimigrated via met pathway, He believed that the effect of SEMA4D/Plexin-B1 mainly depended on the superior pathway. The gene discussed is NTRK1; the disease is neoplasm.